Putnam Investments LLC Harmony Biosciences Holdings, Inc. Transaction History

Putnam Investments LLC

  • $73 Billion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 22, 2023
SELL
$30.8 - $53.92 $799,722 - $1.4 Million
-25,965 Reduced 19.16%
109,547 $3.58 Million
Q4 2022

Feb 14, 2023
BUY
$45.4 - $60.91 $925,479 - $1.24 Million
20,385 Added 17.71%
135,512 $7.47 Million
Q3 2022

Nov 14, 2022
BUY
$42.06 - $55.45 $4.84 Million - $6.38 Million
115,127 New
115,127 $5.1 Million

Others Institutions Holding HRMY

# of Institutions
243
Shares Held
45.2M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.94B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email